UNCY
Unicycive Therapeutics Inc
NASDAQ: UNCY · HEALTHCARE · BIOTECHNOLOGY
$7.66
+6.98% today
Updated 2026-04-30
Market cap
$180.96M
P/E ratio
—
P/S ratio
23.75x
EPS (TTM)
$-1.67
Dividend yield
—
52W range
$4 – $11
Volume
0.5M
Unicycive Therapeutics Inc (UNCY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-775000.00 | $-1.18M | $-1.46M | $-5.77M | $-15.65M | $-18.28M | $-28.57M | $-31.32M |
| Capital expenditures | $29000.00 | $29000.00 | $29000.00 | $29000.00 | $2000.00 | $12000.00 | $72000.00 | $24000.00 |
| Depreciation | $13000.00 | $13000.00 | $13000.00 | $13000.00 | $161000.00 | $284000.00 | $428000.00 | — |
| Stock-based comp | — | $24000.00 | $232000.00 | $966000.00 | $1.05M | $1.77M | $2.35M | $2.64M |
| Free cash flow | $-804000.00 | $-1.21M | $-1.49M | $-5.80M | $-15.65M | $-18.30M | $-28.65M | $-31.34M |
| Investing cash flow | $-29000.00 | $-29000.00 | $-29000.00 | $-29000.00 | $-2000.00 | $-12000.00 | $-72000.00 | — |
| Financing cash flow | $800000.00 | $1.17M | $1.44M | $22.38M | $-471000.00 | $27.54M | $45.09M | — |
| Dividends paid | — | — | — | — | — | $867000.00 | $1.09M | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |